Últimas noticias sobre CCSC Technology (NASDAQ:CCTG) Bolsa

CCSC Technology

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.

CCSC Technology International Holdings Limited - Class A Ordinary Shares

CCSC Technology International Holdings Ltd

Investors with a lot of money to spend have taken a bearish stance on DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DASH, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 12 options trades for DoorDash.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 58%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $32,065, and 11, calls, for a total amount of $996,583.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $130.0 to $190.0 for DoorDash during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for DoorDash's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across DoorDash's significant trades, within a strike price range of $130.0 to $190.0, over the past month.
<h3>DoorDash Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731947439_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$25.9</td>
<td>$25.55</td>
<td>$25.75</td>
<td>$150.00</td>
<td>$374.7K</td>
<td>2.5K</td>
<td>145</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.68</td>
<td>$1.01</td>
<td>$1.22</td>
<td>$190.00</td>
<td>$118.0K</td>
<td>68</td>
<td>1.0K</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$40.2</td>
<td>$39.7</td>
<td>$39.85</td>
<td>$135.00</td>
<td>$79.7K</td>
<td>1.6K</td>
<td>71</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$40.55</td>
<td>$39.85</td>
<td>$39.85</td>
<td>$135.00</td>
<td>$79.7K</td>
<td>1.6K</td>
<td>27</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$40.25</td>
<td>$40.0</td>
<td>$40.0</td>
<td>$135.00</td>
<td>$76.0K</td>
<td>1.6K</td>
<td>143</td>
</tr>
</tbody>
</table>

<h3>About DoorDash</h3>
Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the US. Through the acquisition of Wolt in 2022, the firm also provides this service in Europe. DoorDash provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers.
After a thorough review of the options trading surrounding DoorDash, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is DoorDash Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 598,876, the DASH's price is up by 2.57%, now at $173.78. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 87 days.</li>
</ul>
<h3>Professional Analyst Ratings for DoorDash</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $179.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from B of A Securities persists with their Buy rating on DoorDash, maintaining a target price of $172. 
&#x2A; An analyst from Jefferies persists with their Buy rating on DoorDash, maintaining a target price of $180. 
&#x2A; Maintaining their stance, an analyst from JMP Securities continues to hold a Market Outperform rating for DoorDash, targeting a price of $190. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on DoorDash, maintaining a target price of $175. 
&#x2A; An analyst from BMO Capital persists with their Outperform rating on DoorDash, maintaining a target price of $180. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for DoorDash with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

DASH

Decoding DoorDash's Options Activity: What's the Big Picture?

Investors with a lot of money to spend have taken a bullish stance on First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with FSLR, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for First Solar.
This isn't normal.
The overall sentiment of these big-money traders is split between 77% bullish and 22%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $149,230, and 6 are calls, for a total amount of $299,265.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $180.0 to $230.0 for First Solar during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for First Solar options trades today is 1704.12 with a total volume of 671.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for First Solar's big money trades within a strike price range of $180.0 to $230.0 over the last 30 days.
<h3>First Solar Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731947434_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FSLR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$19.75</td>
<td>$18.7</td>
<td>$19.1</td>
<td>$195.00</td>
<td>$95.4K</td>
<td>6</td>
<td align="right">59</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$17.5</td>
<td>$17.35</td>
<td>$17.35</td>
<td>$195.00</td>
<td>$72.8K</td>
<td>620</td>
<td align="right">43</td>
</tr>
<tr>
<td>FSLR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.25</td>
<td>$2.03</td>
<td>$2.25</td>
<td>$230.00</td>
<td>$56.2K</td>
<td>3.5K</td>
<td align="right">260</td>
</tr>
<tr>
<td>FSLR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$13.7</td>
<td>$13.65</td>
<td>$13.65</td>
<td>$200.00</td>
<td>$54.6K</td>
<td>1.7K</td>
<td align="right">67</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$23.55</td>
<td>$22.5</td>
<td>$22.5</td>
<td>$180.00</td>
<td>$45.0K</td>
<td>7.4K</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About First Solar</h3>
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.
<h3>Present Market Standing of First Solar</h3>
<ul>
<li>Trading volume stands at 610,149, with FSLR's price up by 1.29%, positioned at $192.91.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 99 days.</li>
</ul>
<h3>Expert Opinions on First Solar</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $276.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on First Solar with a target price of $269. 
&#x2A; In a cautious move, an analyst from BMO Capital downgraded its rating to Outperform, setting a price target of $260. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for First Solar, targeting a price of $240. 
&#x2A; An analyst from Guggenheim persists with their Buy rating on First Solar, maintaining a target price of $335. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on First Solar, maintaining a target price of $280. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest First Solar options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

FSLR

Smart Money Is Betting Big In FSLR Options

Financial giants have made a conspicuous bullish move on Constellation Energy. Our analysis of options history for Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) revealed 14 unusual trades.
Delving into the details, we found 64% of traders were bullish, while 7% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $1,244,283, and 9 were calls, valued at $926,647.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $190.0 to $410.0 for Constellation Energy during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Constellation Energy's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Constellation Energy's whale activity within a strike price range from $190.0 to $410.0 in the last 30 days. 
<h3>Constellation Energy Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731947428_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CEG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.2</td>
<td>$2.95</td>
<td>$2.96</td>
<td>$190.00</td>
<td>$877.0K</td>
<td>278</td>
<td>2.9K</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.3</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$250.00</td>
<td>$235.3K</td>
<td>2.9K</td>
<td>900</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.1</td>
<td>$8.0</td>
<td>$8.0</td>
<td>$250.00</td>
<td>$201.6K</td>
<td>2.9K</td>
<td>350</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.8</td>
<td>$5.4</td>
<td>$5.65</td>
<td>$240.00</td>
<td>$197.7K</td>
<td>704</td>
<td>364</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.3</td>
<td>$8.2</td>
<td>$8.2</td>
<td>$250.00</td>
<td>$98.3K</td>
<td>2.9K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Constellation Energy</h3>
Constellation Energy Corp offers energy solutions. It provides clean energy and sustainable solutions to homes, businesses, the public sector, community aggregations, and a range of wholesale customers (such as municipalities, cooperatives, and other strategics). The company offers comprehensive energy solutions and a variety of pricing options for electric, natural gas, and renewable energy products for companies of any size.
Having examined the options trading patterns of Constellation Energy, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Constellation Energy</h3>
<ul>
<li>With a volume of 693,133, the price of CEG is up 1.6% at $227.87. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 99 days.</li>
</ul>
<h3>What The Experts Say On Constellation Energy</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $280.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Constellation Energy with a target price of $298. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Constellation Energy, which currently sits at a price target of $282. 
&#x2A; An analyst from BMO Capital has decided to maintain their Outperform rating on Constellation Energy, which currently sits at a price target of $291. 
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Constellation Energy with a target price of $298. 
&#x2A; An analyst from Mizuho persists with their Neutral rating on Constellation Energy, maintaining a target price of $235. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Constellation Energy options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Constellation Energy's Options Frenzy: What You Need to Know

Wedbush analyst David Nierengarten reiterates Chimerix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMRX#NASDAQ">CMRX</a>) with a Outperform and maintains $6 price target.

News

Price Target

Reiteration

Analyst Ratings

CMRX

Wedbush Reiterates Outperform on Chimerix, Maintains $6 Price Target

WIIM

COIN

Coinbase shares are trading higher after Needham maintained a Buy rating on the stock and raised its price target from $290 to $375.

The U.S. Department of Agriculture (USDA) <a href="https://www.ams.usda.gov/content/usda-extends-enforcement-deadline-hemp-be-tested-dea-registered-laboratories-1">has once again postponed</a> the enforcement of a requirement for <a href="https://www.benzinga.com/topic/hemp">hemp</a> testing to be conducted by Drug Enforcement Administration (DEA)-registered laboratories, granting the industry another year of flexibility. Under this extension, hemp produced through the USDA&#8217;s Domestic Hemp Production Program can continue to be tested at non-DEA-certified labs until December 31, 2025.
The decision marks the third time the USDA <a href="https://www.benzinga.com/markets/cannabis/22/12/30047125/usda-delays-enforcement-of-rules-requiring-hemp-to-be-tested-by-dea-registered-labs-heres-why">has pushed back</a> this requirement. Initially <a href="https://www.ams.usda.gov/content/usda-extends-enforcement-deadline-hemp-be-tested-dea-registered-laboratories">set to take effect</a> by Jan. 1, 2023, the mandate was previously delayed, citing similar concerns over testing capacity.
<h3 class="wp-block-heading">Industry Feedback and Certification Hurdles</h3>
The USDA attributed the delay to <a href="https://www.benzinga.com/markets/cannabis/24/01/36743012/usda-intensifies-hemp-industry-analysis-with-nationwide-farmer-surveys">ongoing feedback</a> from state and tribal governments, as well as third-party cannabis testing facilities, highlighting significant delays in the DEA's laboratory registration process. &#8220;Because of these setbacks in the completion of the DEA process, USDA is concerned there will be inadequate approved hemp laboratory testing capacity for the 2025 growing season,&#8221; the agency stated.
The delay underscores the industry&#8217;s struggle to meet the stringent requirements set by the DEA, with many testing facilities facing barriers to obtaining certification. As a result, the USDA has opted for a temporary extension, allowing the industry more time to align with federal testing standards while continuing to rely on non-DEA-certified labs.
<h3 class="wp-block-heading">Immediate Enforcement Discretion</h3>
In a move that bypasses the usual public notice and comment period, the USDA exercised its discretion to implement the extension immediately. The agency noted that potential market entrants and related industries require clear guidance for their preparations ahead of the 2025 growing season, making it essential to provide an immediate solution without further procedural delays.
The USDA's notice emphasized that while the requirement for DEA certification is delayed, laboratories testing hemp must still comply with all other regulatory requirements. The decision aims to prevent disruption in the testing process, which is critical for ensuring compliance and safety in the hemp market.
<h3 class="wp-block-heading">Declining Hemp Production Compounds Challenges</h3>
The extension comes at a time of <a href="https://www.benzinga.com/markets/cannabis/23/12/36074182/congressional-report-sheds-light-on-hemps-impact-and-future-prospects-amid-farm-bill-renewal-tal">declining hemp production</a> in the U.S. According to the USDA&#8217;s most recent National Hemp Report, indoor hemp cultivation has dropped sharply, from 15.5 million square feet in 2021 to just 3.2 million square feet in 2023. Outdoor hemp acreage has also seen a decline, with 27,680 acres reported in 2023 &#8211; a 2% decrease compared to the previous year.
This downturn in production, combined with <a href="https://www.benzinga.com/markets/cannabis/24/10/41576666/from-reefer-madness-to-regulatory-madness-the-fdas-impact-on-the-u-s-hemp-industry">regulatory hurdles</a>, poses significant challenges for the industry. By delaying the DEA certification requirement, the USDA aims to provide hemp producers with the necessary breathing space to adapt while ensuring testing processes remain accessible.
<h3 class="wp-block-heading">Looking Ahead</h3>
The USDA&#8217;s decision to extend the deadline reflects the agency&#8217;s recognition of the practical difficulties faced by the hemp industry. However, the reliance on non-DEA-certified labs highlights the ongoing capacity issues that must be resolved to meet federal standards in the long term.
Cover image created with AI

Cannabis

Government

USDA Extends Hemp Testing Flexibility, Postpones DEA Lab Certification Rule

Wedbush analyst Daniel Ives reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and maintains $400 price target.

TSLA

Wedbush Reiterates Outperform on Tesla, Maintains $400 Price Target

TOKYO -- U.S. business software provider ServiceNow plans to invest $2 billion in Japan over the next few years to expand its data center operation and local office, CEO Bill McDermott has told&nbsp;Nikkei.
Part of the spending will go toward data center expansion to accommodate the increase in client companies and enhance&nbsp;services that use generative artificial intelligence.
<a href="https://asia.nikkei.com/Business/Technology/U.S.-tech-firm-ServiceNow-to-spend-2bn-on-Japan-data-center-push" title="https://asia.nikkei.com/Business/Technology/U.S.-tech-firm-ServiceNow-to-spend-2bn-on-Japan-data-center-push">https://asia.nikkei.com/Business/Technology/U.S.-tech-firm-ServiceNow-to-spend-2bn-on-Japan-data-center-push</a>

'U.S. tech firm ServiceNow to spend $2bn on Japan data center push' -Nikkei

Barclays analyst Ramsey El-Assal maintains Remitly Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) with a Overweight and raises the price target from $20 to $23.

RELY

Barclays Maintains Overweight on Remitly Global, Raises Price Target to $23

BMO Capital analyst Kelly Bania maintains Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Market Perform and lowers the price target from $90 to $80.

BMO Capital Maintains Market Perform on Dollar Gen, Lowers Price Target to $80

Barclays analyst John Coffey maintains StoneCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) with a Equal-Weight and lowers the price target from $13 to $12.

STNE

Barclays Maintains Equal-Weight on StoneCo, Lowers Price Target to $12

BMO Capital analyst Kelly Bania maintains Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) with a Market Perform and lowers the price target from $68 to $65.

DLTR

BMO Capital Maintains Market Perform on Dollar Tree, Lowers Price Target to $65

Wedbush analyst David Nierengarten reiterates Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) with a Neutral and maintains $14 price target.

NTLA

Wedbush Reiterates Neutral on Intellia Therapeutics, Maintains $14 Price Target

Barclays analyst Simon Coles maintains Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) with a Overweight and raises the price target from $215 to $240.

Barclays Maintains Overweight on Taiwan Semiconductor, Raises Price Target to $240

BMO Capital analyst Kelly Bania maintains Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) with a Outperform and raises the price target from $980 to $1075.

COST

BMO Capital Maintains Outperform on Costco Wholesale, Raises Price Target to $1075

Trading Ideas

PLAG

Planet Green Holdings Shares Halted To The Downside; Stock Now Down -4.42%

Wedbush analyst Nick Setyan maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Outperform and lowers the price target from $60 to $50.

JACK

Wedbush Maintains Outperform on Jack In The Box, Lowers Price Target to $50

BMO Capital analyst Kelly Bania maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Outperform and raises the price target from $80 to $100.

BMO Capital Maintains Outperform on Walmart, Raises Price Target to $100

Biotech

General

BBIO

BridgeBio Pharma Says The Continued Curve Separation Of The Composite Endpoint Of ACM And Recurrent Cardiovascular-Related Hospitalizations Emphasizes The Importance Of Early Intervention Resulting In Early And Sustained Clinical Benefits, With Acoramidis Demonstrating 46% And 48% Reductions In The Composite Endpoint Of ACM And Recurrent CVH At Months 36 And 42, Respectively

- Acoramidis demonstrated the earliest known time to separation in cardiovascular outcomes in the ATTRibute-CM study (3 months), with statistically significant risk reduction of 36% on All-Cause Mortality (ACM) alone at Month 36 within the Open Label Extension
- The continued curve separation of the composite endpoint of ACM and recurrent cardiovascular-related hospitalizations (CVH) emphasizes the importance of early intervention resulting in early and sustained clinical benefits, with acoramidis demonstrating 46% (p&lt;0.0001) and 48% (p&lt;0.0001) reductions in the composite endpoint of ACM and recurrent CVH at Months 36 and 42, respectively
- The preliminary results from this ongoing OLE study were also <a href="https://www.globenewswire.com/Tracker?data=nVrCQc_8jzuW0us-lfgFaR1qVTq_ZKK094j0nAXwGOzjpiNvmiPryHA11xPFHhBaYgKeFEBHeF4VNpSc_nsfEV21llyp7gkCWZiQNzvNSBAxj8g76mpygGVWg7b6bJ3rrNNv9OwALUuytnCVMDnjfDM4znS65x927SjyqqRsPQ4YxLUlnW0b98_MjiwYp5E1">simultaneously published in&nbsp;Circulation</a>
- A New Drug Application for acoramidis for the treatment of ATTR-CM is currently under review with the FDA, with a PDUFA action date of November 29, 2024
PALO ALTO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) ("BridgeBio" or the "Company"), a&nbsp;new type of biopharmaceutical company focused on genetic diseases, presented positive initial outcomes from the ATTRibute-CM open-label extension (OLE) study of acoramidis in ATTR-CM at the American Heart Association (AHA) Scientific Sessions. ATTRibute-CM was designed to evaluate the efficacy and safety of acoramidis, an investigational, near-complete, orally-administered, small molecule stabilizer of TTR. The preliminary results from this ongoing OLE study were also <a href="https://www.globenewswire.com/Tracker?data=nVrCQc_8jzuW0us-lfgFaR1qVTq_ZKK094j0nAXwGOzjpiNvmiPryHA11xPFHhBaeIlDqZKG7OqhCoe56sd754bjgDVGcOiJ2s8HyuUyG7NflQCmEEQ3lIVaCQMHailwHLZaiAioFHGbJQ3YCr7zBvPyWKH7hTdh2uwLa8ooRVkFlNr8o40ZFfvRncYmj6k3">simultaneously published in&nbsp;Circulation</a>. The OLE study involves 330 participants who completed the 30-month ATTRibute-CM Phase 3 study.

BridgeBio Pharma Presented Initial Outcomes From The ATTRibute-CM Open-label Extension Study Of Acoramidis In ATTR-CM At The AHA Scientific Sessions; Acoramidis Demonstrated The Earliest Known Time To Separation In Cardiovascular Outcomes In The  ATTRibute-CM Study (3 Months), With Statistically Significant Risk Reduction Of 36% On All-Cause Mortality Alone At Month 36 Within The Open Label Extension

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday!



Moving stocks this morning are business combinations, earnings reports, and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) stock is rocketing more than 39% alongside heavy pre-market trading.</li>



<li>First Wave BioPharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/fwbi-stock-quote/">FWBI</a>) shares are soaring over 33% after <a href="https://www.globenewswire.com/news-release/2024/03/14/2846098/0/en/First-Wave-BioPharma-Announces-Completion-of-Business-Combination-with-ImmunogenX-Adding-Phase-3-Ready-Latiglutenase-to-its-Late-Stage-GI-Focused-Clinical-Pipeline.html">completing a business combination</a>.</li>



<li>Turtle Beach (NASDAQ:<a href="https://investorplace.com/stock-quotes/hear-stock-quote/">HEAR</a>) stock is surging more than 28% after announcing <a href="https://www.nasdaq.com/press-release/turtle-beach-announces-transformational-acquisition-of-pdp-and-intention-to-launch">acquisition plans for PDP</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) shares are increasing over 26%, with strong early morning trading this morning.</li>



<li>ShiftPixy (NASDAQ:<a href="https://investorplace.com/stock-quotes/pixy-stock-quote/">PIXY</a>) stock is gaining more than 21% as it <a href="https://investorplace.com/2024/03/why-is-shiftpixy-pixy-stock-up-52-today/">continues a recent rally</a>.</li>



<li>DHC Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/dhca-stock-quote/">DHCA</a>) shares are rising close to 21% on <a href="https://www.businesswire.com/news/home/20240313400845/en/BEN-Announces-Expected-Closing-of-Business-Combination">plans to close a business combination</a>.</li>



<li>BOS Better Online Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/bosc-stock-quote/">BOSC</a>) stock is climbing nearly 19% this morning.</li>



<li>Spero Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/spro-stock-quote/">SPRO</a>) shares are heading over 18% higher with a <a href="https://finance.yahoo.com/news/spero-therapeutics-inc-spro-q4-211003604.html">positive Q4 earnings report</a>.</li>



<li>Ucloudlink (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucl-stock-quote/">UCL</a>) stock is jumping more than 17% after <a href="https://www.nasdaq.com/press-release/ucloudlink-group-inc.-announces-unaudited-fourth-quarter-and-full-year-2023-financial">releasing its Q4 earnings report</a>.</li>



<li>New Horizon Aircraft (NASDAQ:<a href="https://investorplace.com/stock-quotes/hovr-stock-quote/">HOVR</a>) shares are up over 14% <a href="https://www.nasdaq.com/press-release/horizon-aircraft-to-participate-in-the-36th-annual-roth-conference-on-march-18-and-19">ahead of a conference next week</a>.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>Spruce Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprb-stock-quote/">SPRB</a>) stock is crashing more than 73% alongside its <a href="https://finance.yahoo.com/news/spruce-biosciences-reports-full-2023-200800244.html">latest earnings report</a> and <a href="https://finance.yahoo.com/news/spruce-biosciences-announces-topline-results-200100871.html">clinical trial data</a>.</li>



<li>Fisker (NYSE:<a href="https://investorplace.com/stock-quotes/fsr-stock-quote/">FSR</a>) stock is plummeting over 38% on reports its <a href="https://www.wsj.com/business/autos/electric-vehicle-startup-fisker-prepares-for-possible-bankruptcy-filing-26e63d32">considering a bankruptcy filing</a>.</li>



<li>Solidion Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/sti-stock-quote/">STI</a>) shares are diving more than 34% after <a href="https://www.nasdaq.com/press-release/solidion-technology-inc.-announces-pricing-of-%243.85-million-private-placement-2024-03">pricing a private placement</a>.</li>



<li>Hello (NASDAQ:<a href="https://investorplace.com/stock-quotes/momo-stock-quote/">MOMO</a>) stock is tumbling over 16% with the release of its <a href="https://www.nasdaq.com/press-release/hello-group-inc.-announces-unaudited-financial-results-for-the-fourth-quarter-and-1">Q4 earnings report</a>.</li>



<li>Pagaya Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/pgy-stock-quote/">PGY</a>) shares are taking a more than 14% beating after <a href="https://finance.yahoo.com/news/pagaya-announces-public-offering-class-204000211.html">announcing a public offering</a>.</li>



<li>Erayak Power Solution (NASDAQ:<a href="https://investorplace.com/stock-quotes/raya-stock-quote/">RAYA</a>) stock is sliding over 14% this morning.</li>



<li>Qilian (NASDAQ:<a href="https://investorplace.com/stock-quotes/qli-stock-quote/">QLI</a>) shares are decreasing more than 13% on Thursday morning.</li>



<li>PLBY Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/plby-stock-quote/">PLBY</a>) stock is dropping over 13% after <a href="https://ca.investing.com/news/stock-market-news/plby-group-to-restate-financials-reducing-net-losses-93CH-3299860">restating financial results</a>.</li>



<li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) shares are falling more than 13% this morning.</li>



<li>Global Gas (NASDAQ:<a href="https://investorplace.com/stock-quotes/hgas-stock-quote/">HGAS</a>) stock closes our out pre-market stock movers down over 13%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-march-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Blade Air Mobility, NuScale Power, XTI Aerospace among industrial movers

PERI, ITRM and CADL among pre-market losers

CCSC Technology International Holdings Limited (CCTG) has released an update. CCSC Technology International Holdings Limited has appointed a new Ch...

CCSC Appoints New Chief Strategy Officer

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Wednesday as we offer up all the latest news sending shares higher and lower this morning!



Moving stocks this morning are continued rallies, heavy trading, clinical trials and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Akoustis Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/akts-stock-quote/">AKTS</a>) stock is rocketing more than 142% alongside heavy pre-market trading.</li>



<li>Mustang Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/mbio-stock-quote/">MBIO</a>) shares are soaring over 82% with strong early morning trading.</li>



<li>MGO Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgol-stock-quote/">MGOL</a>) stock is surging more than 68% as it <a href="https://investorplace.com/2024/05/why-is-mgo-global-mgol-stock-up-106-today/">continues to rally</a>.</li>



<li>Barnes &amp; Noble Education (NYSE:<a href="https://investorplace.com/stock-quotes/bned-stock-quote/">BNED</a>) shares are gaining close to 54% as its <a href="https://investorplace.com/2024/05/what-is-going-on-with-barnes-noble-education-bned-stock-today/">rally yesterday continues</a>.</li>



<li>Rezolute (NASDAQ:<a href="https://investorplace.com/stock-quotes/rzlt-stock-quote/">RZLT</a>) stock is rising over 31% after <a href="https://www.nasdaq.com/press-release/rezolute-reports-positive-topline-results-from-phase-2-proof-of-concept-study-of">releasing positive study results</a>.</li>



<li>DermTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/">DMTK</a>) shares are increasing more than 28% with heavy trading this morning.</li>



<li>Mangoceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgrx-stock-quote/">MGRX</a>) stock is heading over 22% higher after <a href="https://investorplace.com/2024/05/why-is-mangoceuticals-mgrx-stock-up-130-today/">rallying yesterday too</a>.</li>



<li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) shares are climbing more than 19% without any clear news this morning.</li>



<li>Eupraxia Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/eprx-stock-quote/">EPRX</a>) stock is jumping over 15% on <a href="https://www.marketwatch.com/story/eupraxia-pharmaceuticals-shares-pop-after-new-trial-data-4e20f13b?mod=newsviewer_click">new drug trial data</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) shares are up more than 15% despite a lack of news.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is diving over 24% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318339015&amp;type=PDF&amp;symbol=CRKN&amp;cdn=9fd92bcd34f4f2180730286b7103ecb0&amp;companyName=Crown+Electrokinetics+Corp.&amp;formType=DEF+14A&amp;formDescription=Other+definitive+proxy+statements&amp;dateFiled=2024-05-21">announcing shareholder meeting plans</a>.</li>



<li>Edible Garden (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) shares are tumbling more than 24% without any apparent news to report.</li>



<li>Euronav (NYSE:<a href="https://investorplace.com/stock-quotes/eurn-stock-quote/">EURN</a>) stock is taking an over 20% beating on no clear news this morning.</li>



<li>Sintx Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sint-stock-quote/">SINT</a>) shares are sliding nearly 19% on Wednesday morning.</li>



<li>FLJ Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/flj-stock-quote/">FLJ</a>) stock is dropping more than 16% this morning.</li>



<li>Cheetah Net Supply Chain (NASDAQ:<a href="https://investorplace.com/stock-quotes/ctnt-stock-quote/">CTNT</a>) shares are falling over 16% as they continue to drop.</li>



<li>LifeStance Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfst-stock-quote/">LFST</a>) stock is decreasing more than 15% after <a href="https://www.nasdaq.com/press-release/lifestance-health-group-announces-pricing-of-secondary-public-offering-2024-05-21">pricing a secondary offering</a>.</li>



<li>Chijet Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/cjet-stock-quote/">CJET</a>) shares are dipping over 15% after rallying yesterday.</li>



<li>Meta Data (NYSE:<a href="https://investorplace.com/stock-quotes/aiu-stock-quote/">AIU</a>) stock is slipping more than 15% today.</li>



<li>Vicarious Surgical (NYSE:<a href="https://investorplace.com/stock-quotes/rbot-stock-quote/">RBOT</a>) shares close out our pre-market stock movers down over 14% on a <a href="https://www.investing.com/news/company-news/vicarious-surgical-ceo-sells-shares-worth-9506-93CH-3450561">CEO share sale</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-may-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Greenwave Technology, FREYR Battery, Golden Ocean among industrial movers

IPO Roundup: Ardent Health, TWFG, Artiva Biotherapeutics, and more

CCSC Technology International Holdings GAAP EPS of -$0.13, revenue of $14.7M

CCSC Technology International Holdings Limited (CCTG) has released an update. CCSC Technology International Holdings Limited has announced its Annu...

CCSC Technology International's Key AGM Proposals

CCSC Technology International Holdings Limited (CCTG) has released an update. CCSC Technology International Holdings Limited recently convened its ...

CCSC Technology Shareholders Approve Key Resolutions

ACTU

ADIL

AKTS

ALUR

ARDT

ARTV

BACQU

BLMZ

BNED

BOSC

BRTX

BTOG

CADL

CCTG

CJET

CRKN

CTNT

DATS

DHCA

DMTK

EDBL

EPRX

EURN

FLAI

FLGC

FWBI

HEAR

HGAS

HOVR

HUBC

IAUX

IONM

ITRM

KSPI

LFST

LPAAU

LRTX

MBIO

MDIA

MGOL

MGRX

MOMO

PERI

PGHL

PIXY

PLBY

PRST

RAYA

RBOT

RZLT

SERV

SGLY

SINT

SOAR

SPIR

SPRB

SPRO

TWFG

VRME

VSME

VVPR

XXII

ZCMD

ZOOZ

Earnings

Press Releases

CCSC Technology International Holdings Limited Reports Financial Results for the First Six Months of Fiscal Year 2024

Small Cap

Opinion

Thinking about buying stock in CXApp, CCSC Technology International, Vroom, Spero Therapeutics, or OptiNose?

CCSC Technology International Holdings Limited Appoints Jung Yi Chiu as Chief Strategy Officer

CCSC Technology International Holdings Limited Announces Plan for New Supply Chain Management Center in Central Europe

New European Supply Chain Center to Enhance Global Growth of Interconnected Products Needed in a Wide Range of Industries: CCSC Technology International Holdings Limited (Nasdaq: CCTG)

CCSC Technology International Holdings Limited Enters into Strategic Cooperation Framework Agreement with Innogetic International Limited

CCSC Technology International Holdings Limited Enters into International Purchase Agreement with SHI / LIGHTCARE-SOLUTIONS ApS

New International Agreements for AI Applications and Healthcare Lighting, Plus Plans for European Supply Chain Center to Serve Varied Tech Industries: CCSC Technology (Nasdaq: CCTG)

CCSC Technology International Holdings Limited Reports Financial Results for Fiscal Year 2024

Comments

CCSC Technology

Noticias

Últimas noticias sobre CCSC Technology (NASDAQ:CCTG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL